| Reserpine, the major component of alseroxylon | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| CAS Number | |
| DrugBank | |
| ChemSpider |
|
| UNII |
|
| ChEMBL | |
| Chemical and physical data | |
| Formula | Varies |
| | |
Alseroxylon (Rautensin, Rauwiloid) is a norepinephrine reuptake inhibitor that has been investigated in the treatment of hypertension [1] and angina pectoris and as a sedative in psychosis. [2] It was at one time approved for use in the United States, but has since been discontinued. [3]
Alseroxylon is a purified fat-soluble extract of the root of Rauvolfia serpentina , containing reserpine and other nonadrenolytic amorphous alkaloids. [2]
{{cite book}}: |work= ignored (help)